argenx SE (ARGX) stock
ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$941.25−6.27 (-0.66%)
Close on Nov 18, 2026Market cap –P/E 48.1Yield –
argenx shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2025 it was 66M, up 1.3% from the year before. Over ten years it grew 15.4% a year on average. The highest annual figure on record is 66M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 66M | +1.3% |
| FY2024 | Dec 31, 2024 | 65M | +14.0% |
| FY2023 | Dec 31, 2023 | 57M | +5.1% |
| FY2022 | Dec 31, 2022 | 54M | +6.5% |
| FY2021 | Dec 31, 2021 | 51M | +12.5% |
| FY2020 | Dec 31, 2020 | 45M | +17.6% |
| FY2019 | Dec 31, 2019 | 39M | +15.6% |
| FY2018 | Dec 31, 2018 | 33M | +35.8% |
| FY2017 | Dec 31, 2017 | 25M | +30.8% |
| FY2016 | Dec 31, 2016 | 19M | +19.6% |
| FY2015 | Dec 31, 2015 | 16M | – |
See a number that looks wrong?